Study guide

14.5 Returning to Dialysis After Graft Failure

BONENT Certified Hemodialysis Nurse CHN

Track your progress as you read

Finished sections get a check mark.

1 Exam Orientation

1.1 Current CHN Exam Facts and Study Strategy

2 Chapter 1: Renal Anatomy, Physiology & CKD Pathophysiology

2.1 Nephron Physiology & Endocrine Functions 2.2 Acute Kidney Injury & Chronic Kidney Disease Staging 2.3 Fluid, Electrolyte & Acid-Base Imbalances in ESRD

3 Chapter 2: CKD-MBD, Uremia & Clinical Manifestations

3.1 CKD-Mineral and Bone Disorder (CKD-MBD) 3.2 Uremic Syndrome & Multi-System Complications 3.3 Dialysis Patient Education & Nutritional Management

4 Individualized Nursing Care

4.1 Nursing Assessment, Planning and Evaluation 4.2 Treatment Records and Safe Handoffs 4.3 Psychosocial Assessment, Counseling and Referral

5 Chapter 3: Principles of Hemodialysis & Dialysate Chemistry

5.1 Transport Mechanisms: Diffusion, Convection & Ultrafiltration 5.2 Dialyzer Characteristics, Membrane Biocompatibility & Flux 5.3 Dialysate Composition & Concentrate Formulations 5.4 Hemodialysis Adequacy: Urea Kinetics, Kt/V & URR

6 Chapter 4: Vascular Access: Fistulas, Grafts & Catheters

6.1 Arteriovenous Fistulas & Arteriovenous Grafts 6.2 Physical Examination, Surveillance & Monitoring of Access 6.3 Central Venous Catheters & CDC Infection Prevention

7 Chapter 5: Cannulation Practice & Access Complications

7.1 Cannulation Techniques: Rope-Ladder, Buttonhole & Needle Sizing 7.2 Vascular Access Stenosis, Thrombosis & Steal Syndrome 7.3 Access Infiltration, Pseudoaneurysms & Hemorrhage Management

8 Chapter 6: Hemodialysis Treatment Delivery & Circuit Monitoring

8.1 Pre-Dialysis Assessment, Target Dry Weight & UFR Limits 8.2 Extracorporeal Circuit Setup, Priming & Safety Alarms 8.3 Anticoagulation Management: Heparin Protocols & Citrate 8.4 Treatment Termination, Hemostasis & Post-Dialysis Assessment

9 Equipment and Laboratory Skills

9.1 Ancillary Equipment and Bedside Safety 9.2 Blood Sampling, Laboratory Trends and Critical Results

10 Chapter 7: Acute Intradialytic Complications & Emergencies

10.1 Intradialytic Hypotension & Muscle Cramping 10.2 Dialysis Disequilibrium Syndrome & Neurological Events 10.3 Dialyzer Reactions & Hypersensitivity (Type A and Type B) 10.4 Critical Emergencies: Air Embolism, Hemolysis & Blood Loss

11 Extended and Acute Treatment

11.1 Sequential UF, Hemofiltration and Hemoperfusion 11.2 Acute Kidney Injury and High-Risk Dialysis Initiation

12 Chapter 8: Nephrology Pharmacology in Hemodialysis

12.1 Anemia Management: ESAs & Intravenous Iron Therapy 12.2 CKD-MBD Pharmacotherapy: Binders, Vitamin D & Calcimimetics 12.3 Cardiovascular, Antimicrobial & Dialyzable Drug Dosing

13 Home and Peritoneal Dialysis

13.1 Home Dialysis Selection and Adult Learning 13.2 Home Setup, Monitoring and Emergency Readiness 13.3 Peritoneal Dialysis Principles and Nursing Care

14 Kidney Transplantation

14.1 Transplant Benefits, Burdens and Modality Counseling 14.2 Transplant Indications, Contraindications and Referral 14.3 Pretransplant Workup and Waiting-List Coordination 14.4 Immunosuppressants, Interactions and Patient Teaching 14.5 Returning to Dialysis After Graft Failure 14.6 New-Graft Monitoring and Urgent Changes

15 Chapter 9: Water Treatment Systems & Dialyzer Reprocessing

15.1 AAMI/ISO Water Treatment Architecture & Components 15.2 Chemical Contaminant Monitoring & Total Chlorine Testing 15.3 Microbiological Standards, Endotoxin Surveillance & Sampling 15.4 Dialyzer Reprocessing Standards, Testing & Germicide Safety

16 Clinical Unit Management

16.1 Evaluating Dialysis Technology and Supplies 16.2 Staffing, Personnel Policies and Standards of Care

17 Chapter 10: Supervision, Administration & Professional Practice

17.1 RN Delegation, Technician Supervision & Nurse Practice Acts 17.2 CMS Conditions for Coverage & Interdisciplinary Care Planning 17.3 Dialysis Unit Infection Control & Environmental Safety 17.4 Quality Improvement (ESRD QIP), Ethics & Palliative Care

18 Professional Development

18.1 Professional Literature, Organizations and Continuing Learning 18.2 Research Design, Implementation and Evidence Interpretation 18.3 Staff Training, Competency and Remediation

19 Environmental Hazards and Emergency Planning

19.1 Chemical Agents, Disinfection and Exposure Control 19.2 Biological Hazards and Occupational Injury Response 19.3 Fire, Threats and Power or Water Interruptions

14.5 Returning to Dialysis After Graft Failure

Key Takeaways Explain This Topic AI

Evaluate urgent dialysis needs and residual graft function in the current clinical context.

Immunosuppression reduction after graft failure is a specialist decision involving infection and sensitization risks.

Reassess access, medications, nutrition, goals and psychological support during the transition.

Last updated: October 2026

Recognize the Transition

A transplanted kidney may lose function through rejection, chronic injury, recurrent disease, infection, vascular problems or other causes. Some deterioration is treatable; some progresses to dialysis dependence. Return to dialysis is therefore a clinical transition rather than a single creatinine threshold. The treating team evaluates reversibility, symptoms, electrolytes, volume and the need for urgent kidney replacement therapy.

The dialysis nurse should know the graft history, recent treatment, current immunosuppression, infection status and transplant-team contacts. Do not relabel every creatinine rise as permanent graft failure. Acute reversible problems can coexist with chronic dysfunction. Conversely, a patient with dangerous hyperkalemia or pulmonary edema may need immediate support while the cause is investigated.

Access and Prescription Planning

Assess whether an old fistula or graft remains patent and usable. Years without dialysis do not guarantee that it can safely support two-needle treatment now. Inspect the skin, thrill, bruit and distal circulation and obtain the appropriate access assessment. If urgent catheter placement is needed, preserve future options through the individualized Life-Plan.

The previous dialysis prescription may be obsolete. Current body composition, residual urine, cardiac state, anemia, medications and metabolic needs differ. Verify a new order rather than copying the regimen from before transplantation. A target weight from several years earlier can be dangerously low or high. Begin with current examination and a cautious, reassessed fluid plan.

Immunosuppression Requires Coordination

After graft failure, continued immunosuppression may preserve residual function or limit sensitization in selected patients, but it also creates infection and other risks. Withdrawal can affect inflammation, graft intolerance and future transplant compatibility. The balance depends on retransplant plans, residual graft function, infection, malignancy and overall goals. The transplant and nephrology teams determine the regimen and taper.

Do not independently stop tacrolimus, mycophenolate or steroids because dialysis has resumed. Do not assume that every patient must continue all therapy indefinitely either. Confirm the explicit plan and responsible prescriber. Long-term corticosteroid withdrawal may also require careful management. Medication reconciliation is especially important when hospital, transplant and dialysis lists disagree.

Residual Function and Graft Symptoms

Urine output may continue despite inadequate filtration, influencing fluid allowance and dialysis needs. Track it accurately and assess trends. A patient who produces urine may still require dialysis for solute control. Diuretics or other prescribed treatment can affect output, so distinguish observed volume from presumed recovery.

Graft pain, fever, hematuria or systemic symptoms need evaluation for infection, rejection-related inflammation or other causes. Graft removal is not automatic for every failed transplant; the specialist team determines indications. Treat fever as potentially urgent, especially while immunosuppression continues. Do not attribute all inflammatory symptoms to 'the old kidney' without investigation.

Rebuild the Ongoing Care Plan

  • Area Transition task
  • Medication Reconcile transplant drugs, renal doses and prophylaxis
  • Access Confirm usable access and future preservation plan
  • Volume Establish a current target with symptoms and residual output
  • Nutrition Review changed needs and practical restrictions
  • Anemia/mineral metabolism Assess trends under the new treatment pattern
  • Psychosocial support Explore grief, fears and burden without blame

Diet advice often changes after returning to dialysis, but it remains individualized. A transplant-era potassium or fluid plan may no longer fit. Review anticoagulation and bleeding risk, including recent biopsy or surgery. Evaluate vaccinations and infection precautions through the appropriate teams rather than assuming the patient now has the same immune status as every maintenance-HD patient.

Emotional and Practical Support

Graft failure can feel like a loss of independence or a personal failure. Ask how the patient is coping and avoid language that assigns blame without evidence. Address depression, uncertainty, transport, work and caregiver strain. A patient who remembers dialysis techniques may still need retraining after years away, particularly with changed machines or access. Prior experience should be acknowledged but verified.

Discuss options including home therapy and retransplant evaluation when appropriate. Not every patient wants or qualifies for another transplant, and counseling should respect informed preferences. Transfusion, infection and medication decisions may affect future sensitization and readiness; communicate them to the transplant program. Immediate safety remains paramount and is not sacrificed to a hypothetical future offer.

Scenario

A patient returns with pulmonary edema after progressive graft dysfunction. The old target weight is six kilograms below the current weight, but the patient has gained tissue mass over several years and is hypotensive. The nurse reports the current examination, urine output and medication list and confirms an individualized prescription. Removing six liters solely to reach the historical number would ignore the patient's present physiology.

The transition succeeds when urgent needs are controlled and the longer-term plan is coherent. Clear responsibility for immunosuppression, access and follow-up prevents the patient from receiving contradictory instructions from different teams.

Source: KDIGO transplant-recipient guidance .